This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: j.jacc.2007.06.012v1 50/12/1115    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (18) Citing Articles via Google Scholar Google Scholar Articles by Hage, F. G. Articles by Szalai, A. J. Search for Related Content PubMed Articles by Hage, F. G. Articles by Szalai, A. J.

STATE-OF-THE-ART PAPER

C-Reactive Protein Gene Polymorphisms, C-Reactive Protein Blood Levels, and Cardiovascular Disease Risk

Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

Manuscript received March 14, 2007; revised manuscript received May 7, 2007, accepted June 5, 2007.

^_* Reprint requests and correspondence: Dr. Fadi G. Hage, 306 Lyons-Harrison Research Building, 1530 3rd Avenue South, Birmingham, Alabama 35294-0007. (Email: fadihage{at}uab.edu).

C-reactive protein (CRP), a blood marker of inflammation and a hallmark of the acute-phase response, has been shown to be a powerful and specific predictor of cardiovascular event risk in populations of otherwise healthy persons. Here we review what is known about CRP gene polymorphisms, discuss how these might affect the epidemiology of CRP and our understanding of CRP’s contribution to cardiovascular disease, and examine their potential clinical usefulness. Evidence shows that certain subtle variations in the CRP gene sequence, mostly single nucleotide polymorphisms, predictably and strongly influence the blood level of CRP. Some of these variations are associated with clinical correlates of cardiovascular disease. If future studies can establish with certainty that CRP influences cardiovascular biology, then CRP gene profiling could have clinical utility.

Abbreviations and Acronyms   CABG = coronary artery bypass graft   CRP = C-reactive protein   IL = interleukin   SLE = systemic lupus erythematosus   SNP = single nucleotide polymorphism

This article has been cited by other articles:

				W. Schumacher, J. Cockcroft, N. J. Timpson, C. M. McEniery, J. Gallacher, A. Rumley, G. Lowe, G. D. Smith, I. B. Wilkinson, and Y. Ben-Shlomo Association Between C-Reactive Protein Genotype, Circulating Levels, and Aortic Pulse Wave Velocity Hypertension, February 1, 2009; 53(2): 150 - 157. [Abstract] [Full Text] [PDF]

				T. B. Grammer, W. Marz, W. Renner, B. O. Bohm, and M. M. Hoffmann C-reactive protein genotypes associated with circulating C-reactive protein but not with angiographic coronary artery disease: the LURIC study Eur. Heart J., January 2, 2009; 30(2): 170 - 182. [Abstract] [Full Text] [PDF]

				Y.-f. Cheung, G.-y. Huang, S.-b. Chen, X.-q. Liu, L. Xi, X.-c. Liang, M.-r. Huang, S. Chen, L.-s. Huang, X.-q. Liu, et al. Inflammatory Gene Polymorphisms and Susceptibility to Kawasaki Disease and Its Arterial Sequelae Pediatrics, September 1, 2008; 122(3): e608 - e614. [Abstract] [Full Text] [PDF]

				A. P. Reiner, M. M. Wurfel, L. A. Lange, C. S. Carlson, A. S. Nord, C. L. Carty, M. J. Rieder, C. Desmarais, N. S. Jenny, C. Iribarren, et al. Polymorphisms of the IL1-Receptor Antagonist Gene (IL1RN) Are Associated With Multiple Markers of Systemic Inflammation Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1407 - 1412. [Abstract] [Full Text] [PDF]

				J. C. Edberg, J. Wu, C. D. Langefeld, E. E. Brown, M. C. Marion, G. McGwin Jr, M. Petri, R. Ramsey-Goldman, J. D. Reveille, S. G. Frank, et al. Genetic variation in the CRP promoter: association with systemic lupus erythematosus Hum. Mol. Genet., April 15, 2008; 17(8): 1147 - 1155. [Abstract] [Full Text] [PDF]